Antimicrobial Activity of Silver Camphorimine Complexes against Candida Strains
Hydroxide [Ag(OH)L] (L = L, L, L, L), oxide [{AgL} }(μ-O)] (L = L, L, L, L, L) or chloride [Ag L]Cl, [Ag( L) ]Cl complexes were obtained from reactions of mono- or bicamphorimine derivatives with Ag(OAc) or AgCl. The new complexes were characterized by spectroscopic (NMR, FTIR) and elemental analysi...
Saved in:
Published in | Antibiotics (Basel) Vol. 8; no. 3; p. 144 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
10.09.2019
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Hydroxide [Ag(OH)L] (L =
L,
L,
L,
L), oxide [{AgL}
}(μ-O)] (L =
L,
L,
L,
L,
L) or chloride [Ag
L]Cl, [Ag(
L)
]Cl complexes were obtained from reactions of mono- or bicamphorimine derivatives with Ag(OAc) or AgCl. The new complexes were characterized by spectroscopic (NMR, FTIR) and elemental analysis. X-ray photoelectron spectroscopy (XPS), ESI mass spectra and conductivity measurements were undertaken to corroborate formulations. The antimicrobial activity of complexes and some ligands were evaluated towards
and
, and strains of the bacterial species
,
,
and
based on the Minimum Inhibitory Concentrations (MIC). Complexes displayed very high activity against the
species studied with the lowest MIC values (3.9 µg/mL) being observed for complexes
and
against
. A significant feature of these redesigned complexes is their ability to sensitize
, a trait that was not found for the previously investigated [Ag(NO
)L] complexes. The MIC values of the complexes towards bacteria were in the range of those of [Ag(NO
)L] and well above those of the precursors Ag(OAc) or AgCl. The activity of the complexes towards normal fibroblasts V79 was evaluated by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay. Results showed that the complexes have a significant cytotoxicity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2079-6382 2079-6382 |
DOI: | 10.3390/antibiotics8030144 |